NL-OMON37564CompletedNot Applicable
Technetium-99m HMPAO granulocyte scintigraphy as a tool to measure inflammatory load in Ulcerative Colitis: a cross-sectional study - STATIC: Scintigraphy To Assess The Inflammatory load In ulcerative Colitis
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational invasive
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •-Age from 18 years, either male or female
- •-Established diagnosis (endoscopic/histological proven) of ulcerative colitis with different severities of disease and irrespective of treatment
- •-Clinical Indication for coloscopy for assessment of disease activity
- •-Obtained written informed consent
- •-A completed Truelove Witts Index
Exclusion Criteria
- •-Toxic Megacolon, colon perforation
- •-Infectious disease (Positive stool culture)
- •-Pregnancy
- •-History of Colectomy
- •-Use of i.v. corticosteroids within the last 36 hours
- •-Renal Failure (eGFR<60)
Investigators
Similar Trials
Terminated
Not Applicable
Developing effective imaging methods to assess chemotherapy response in Malignant Pleural MesotheliomaMesotheliomaCancer - Lung - MesotheliomaACTRN12611000266965Sir Charles Gairdner Hospital15
Active, not recruiting
Phase 1
TOMOSCINTIGRAPHIE HYBRIDE AUX LEUCOCYTES MARQUES DANS LE DIAGNOSTIC DES INFECTIONS DE PROTHESES VASCULAIRES.Etude LEUCOPRO®infection de prothèse vasculaireEUCTR2015-001342-28-FRCHU Angers80
Completed
Phase 2
Technetium 99m labelled macroaggregated albumin administered during selective arterial embolization of renal angiomyolipoma: a biodistribution studyangiomyolipomabenign kidneytumour10038363NL-OMON36687niversitair Medisch Centrum Utrecht10
Not yet recruiting
Phase 3
biquicidin scan to know the cause of FeverCTRI/2019/08/020548Dr Sumeet Suresh Malapure
Active, not recruiting
Phase 1
Scintigraphic detection of tumor necrosis factor with radioactive labeled TNFa-blocker in patients with active rheumatoid arthritis and active axial and peripheric spondyloarthropathy.EUCTR2009-017998-37-BEGhent University Hospital36